For demonstration we applied OptMAVEn to design broadly neutralizing antibody models that target HA and gp120, which are well-know antigens for the influenza [45], [50]–[52] and HIV-1 [46], [53]–[55] viruses, respectively. Here, ITIH4 is linked to influenza.